Treatment Efficacy Voice Disorders Supplement Article
Supplement Article  |   February 01, 1998
Treatment Efficacy
Author Affiliations & Notes
  • Lorraine Olson Ramig
    University of Colorado-Boulder and Wilbur James Gould Voice Research Center Denver Center for the Performing Arts Denver, CO
  • Katherine Verdolini
    Harvard Medical School Boston, MA and Beth Israel Deaconess Medical Center and Brigham and Woman's Hospital Boston, MA and Massachusetts General Hospital Institute of Health Professions Boston, MA
  • Contact author: Lorraine Olson Ramig, PhD, Wilbur James Gould Voice Research Center, Denver Center for the Performing Arts, 1245 Champa Street, Denver, CO 80204-2104
Article Information
Speech, Voice & Prosodic Disorders / Voice Disorders / Supplement: Treatment Efficacy, Part II
Supplement Article   |   February 01, 1998
Treatment Efficacy
Journal of Speech, Language, and Hearing Research, February 1998, Vol. 41, S101-S116. doi:10.1044/jslhr.4101.s101
Journal of Speech, Language, and Hearing Research, February 1998, Vol. 41, S101-S116. doi:10.1044/jslhr.4101.s101
Web of Science® Times Cited: 129

This article reviews the literature on the efficacy of treatment for voice disorders primarily using studies published in peer-reviewed journals. Voice disorders are defined, their frequency of occurrence across the life span is reported, and their impact on the lives of individuals with voice disorders is documented. The goal of voice treatment is to maximize vocal effectiveness given the existing disorder and to reduce the handicapping effect of the voice problem. Voice treatment may be (a) the preferred treatment to resolve the voice disorder when medical (surgical or pharmacological) treatments are not indicated; (b) the initial treatment in cases where medical treatment appears indicated; it may obviate the need for medical treatment; (c) completed before and after surgical treatment to maximize long-term post-surgical voice; and (d) a preventative treatment to preserve vocal health. Experimental and clinical data are reviewed that support these roles applied to various disorder types: (a) vocal misuse, hyperfunction and muscular imbalance (frequently resulting in edema, vocal nodules, polyps or contact ulcers); (b) medical or physical conditions (e.g., laryngeal nerve trauma, Parkinson disease); and (c) psychogenic disorders (e.g., conversion reactions, personality disorders). Directions for future research are suggested which maximize clinical outcomes and scientific rigor to enhance knowledge on the efficacy of voice treatment.

Preparation of this paper was made possible in part by NIH-NIDCD Grants No. R01DC01150, K08DC00139, P60DC00976 and OE-NIDRR Grant No.813340108. Gratitude is expressed to the numerous individuals (including Janina Casper, Daniel Boone, Steve McFarlane, Robert Sataloff, Moya Andrews, Charles Reed, Kristen Baker, Stefanie Countryman, & Annette Arnone Pawlas) who reviewed various drafts of this paper. Appreciation is also expressed to Cynthia Fox, Geron Coale, Heather Hughes, Patricia Hoyt, and Stephanie Hinds who assisted in important ways at various times during the development of this paper.
Order a Subscription
Pay Per View
Entire Journal of Speech, Language, and Hearing Research content & archive
24-hour access
This Article
24-hour access